Alert: Rating Upgrade (5/10/24)-Supernus Pharmaceuticals Inc (NASDAQ: SUPN).
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Supernus Pharmaceuticals Inc (NASDAQ: SUPN) improved of late. SUPN’s current Value Trend Rating is C and the prior Rating was […]